Search

Home > OIS Podcast > What Now? What Does Ophthotech’s Disappointing Phase III Results Mean for Wet AMD, VEGF and PDGF?
Podcast: OIS Podcast
Episode:

What Now? What Does Ophthotech’s Disappointing Phase III Results Mean for Wet AMD, VEGF and PDGF?
Category: Business
Duration: 00:36:33
Publish Date: 2016-12-15 23:00:00
Description: KOLs, CEOs, and analysts say Ophthotech’s disappointing Fovista trials alter the landscape for companies developing new treatments for wet AMD. And all agree, the biggest losers in all of this are patients suffering from the disease.
Total Play: 0